Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32690872 | 0.87 | TSHR (0.61) | SELLSELPCA1CA2TSHR | |
| SCHEMBL217628 | 0.87 | TSHR (0.61) | SELLSELPCA1CA2TSHR | |
| SCHEMBL9623621 | 0.85 | CA1 (0.48) | SELLSELPCA1CA2TSHR | |
| SCHEMBL29941520 | 0.84 | SELL (0.64) | SELLSELPCA1CA2TSHR | |
| SCHEMBL3546145 | 0.84 | SELL (0.64) | SELLSELPCA1CA2TSHR | |
| SCHEMBL2649879 | 0.84 | SELL (0.64) | SELLSELPCA1CA2TSHR | |
| SCHEMBL11055051 | 0.83 | MAPK1 (0.50) | SELLSELPCA1CA2TSHR | |
| SCHEMBL28124327 | 0.81 | MAPK1 (0.48) | SELLSELPCA1CA2TSHR | |
| SCHEMBL8632328 | 0.80 | CA1 (0.48) | SELLSELPCA1CA2TSHR | |
| SCHEMBL31335879 | 0.80 | CA1 (0.48) | SELLSELPCA1CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295689-A1 | Method of Reducing the Expression Level of Inflammatory Biomarkers | THE QUAKER OATS COMPANY | 2025-09-25 | — | — | US | claimed |
| US-20190218340-A1 | BATTERY CASE, BATTERY, LIQUID CRYSTAL POLYMER, AND ARTICLE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-18 | — | — | US | claimed |
| US-20190165336-A1 | BATTERY CASE, BATTERY, LIQUID CRYSTAL POLYMER, AND ARTICLE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-05-30 | — | — | US | claimed |
| US-20090130739-A1 | Deactivation of mineral encapsulated nanobacteria | AMERICAN STERILIZER COMPANY (US) | 2009-05-21 | — | — | US | claimed |
| JP-2007502314-A | — | — | 2007-02-08 | — | — | JP | claimed |
| EP-1633190-A1 | COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES | ISAGRO S.p.A. (IT) | 2006-03-15 | — | — | EP | claimed |
| WO-2004103074-A1 | COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES | ISAGRO S.P.A. (IT) | 2004-12-02 | — | — | WO | claimed |
| US-4874800-A | BLENDED WITH POLYAMIDE TREATED FILLER; HIGH STRENGTH, HEAT RESISTANCE | POLYPLASTICS CO., LTD. (JP) | 1989-10-17 | — | — | US | claimed |
| US-4737398-A | POLYAZOMETHYNE, POLYESTER OR POLYCARBONATE | POLYPLASTICS CO., LTD. (JP) | 1988-04-12 | — | — | US | claimed |
| US-4726998-A | LIQUID CRYSTAL POLYMER SUBSTRATE, MAGNETIC LAYER | POLYPLASTICS CO., LTD. (JP) | 1988-02-23 | — | — | US | claimed |
| US-4092352-A | 2,3-Dichloro-4-hydroxy-benzoic acid and process for preparation thereof | SMITHKLINE CORPORATION (US) | 1978-05-30 | — | — | US | claimed |
| US-12577468-B2 | Thermoplastic compositions and uses thereof | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2026-03-17 | — | — | US | disclosed |
| US-12540221-B2 | Method for manufacturing liquid crystal polymer film | AZOTEK CO., LTD. (TW) | 2026-02-03 | — | — | US | disclosed |
| US-20250295689-A1 | Method of Reducing the Expression Level of Inflammatory Biomarkers | THE QUAKER OATS COMPANY | 2025-09-25 | — | — | US | disclosed |
| US-12421390-B2 | Polymer compositions with improved anti-dent and particulate release performance | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-09-23 | — | — | US | disclosed |
| US-4161470-A | Polyester of 6-hydroxy-2-naphthoic acid and para-hydroxy benzoic acid capable of readily undergoing melt processing | CELANESE CORPORATION (US) | 1979-07-17 | — | — | US | disclosed |
| US-4092352-A | 2,3-Dichloro-4-hydroxy-benzoic acid and process for preparation thereof | SMITHKLINE CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
| US-4092352-A | 2,3-Dichloro-4-hydroxy-benzoic acid and process for preparation thereof | SMITHKLINE CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
| US-4092352-A | 2,3-Dichloro-4-hydroxy-benzoic acid and process for preparation thereof | SMITHKLINE CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
| US-4076839-A | 2,3-DICHLORO-4-CARBOXY-PHENOXYACETIC ACID | SMITHKLINE CORPORATION (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540221-B2 | Method for manufacturing liquid crystal polymer film | MAPT, PYM1, PRNP | SELL 1085/4885SELP 1102/4885CA1 1318/4885 |
| US-12577468-B2 | Thermoplastic compositions and uses thereof | ALAD, ACMSD, DDC | SELL 4189/4885SELP 1758/4885CA1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.